Organization Profile

You just read:

Generex Announces Presentation of Data Correlating Immune Response with Reduction of Relapse in AE37 Phase II Breast Cancer Trial at AACR 2015

News provided by

Generex Biotechnology Corporation

Apr 21, 2015, 09:30 ET